Late Relapse in Testicular Germ Cell Tumours
Author Information
Author(s): Detti Beatrice, Elliott Paul A., McLaren Duncan B., Howard Grahame C.W.
Primary Institution: Edinburgh Cancer Centre, Western General Hospital
Hypothesis
To identify clinicopathological features and outcomes in patients with late relapse of testicular germ cell tumours to guide follow-up policy.
Conclusion
The incidence of late relapse is low, and follow-up after five years may not be justified.
Supporting Evidence
- Six patients (0.85%) relapsed more than 24 months after initial treatment.
- All patients achieved a complete response and remain disease-free with a median follow-up of 52 months.
- Only one patient who relapsed was detected by additional clinic follow-up between 5 and 10 years.
Takeaway
This study looked at patients with testicular cancer who relapsed a long time after treatment and found that most did well with treatment.
Methodology
Retrospective review of patients diagnosed with testicular GCT from 1988 to 2002, focusing on those who relapsed after 24 months.
Limitations
The study is limited by a small number of patients and may not represent broader populations.
Participant Demographics
Median age of participants at initial diagnosis was 39 years, with all presenting initially with stage I disease.
Want to read the original?
Access the complete publication on the publisher's website